Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1981 1
1986 3
1987 12
1988 14
1989 22
1990 32
1991 25
1992 20
1993 19
1994 22
1995 22
1996 21
1997 27
1998 28
1999 26
2000 25
2001 30
2002 12
2003 25
2004 31
2005 36
2006 35
2007 25
2008 42
2009 36
2010 50
2011 47
2012 50
2013 65
2014 39
2015 54
2016 55
2017 42
2018 45
2019 53
2020 56
2021 62
2022 66
2023 46
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,186 results

Results by year

Filters applied: . Clear all
Page 1
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.
Groothoff JW, Metry E, Deesker L, Garrelfs S, Acquaviva C, Almardini R, Beck BB, Boyer O, Cerkauskiene R, Ferraro PM, Groen LA, Gupta A, Knebelmann B, Mandrile G, Moochhala SS, Prytula A, Putnik J, Rumsby G, Soliman NA, Somani B, Bacchetta J. Groothoff JW, et al. Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5. Nat Rev Nephrol. 2023. PMID: 36604599 Review.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Michael M, et al. Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14. Am J Kidney Dis. 2023. PMID: 35843439 Free article. Clinical Trial.
Primary Hyperoxaluria.
Xie X, Zhang X. Xie X, et al. N Engl J Med. 2022 Mar 10;386(10):976. doi: 10.1056/NEJMicm2113369. Epub 2022 Mar 5. N Engl J Med. 2022. PMID: 35245013 No abstract available.
[Oxalate: from physiology to pathology].
Grocholski C, Derain Dubourg L, Guebre-Egziabher F, Acquaviva-Bourdain C, Abid N, Bacchetta J, Chambrier C, Lemoine S. Grocholski C, et al. Nephrol Ther. 2023 Jun 19;19(3):201-214. doi: 10.1684/ndt.2023.10. Nephrol Ther. 2023. PMID: 37166780 Review. French.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, Satoh H, Mourani C, Ariceta G, Torres A, Wolley M, Belostotsky V, Forbes TA, Groothoff J, Hayes W, Tönshoff B, Takayama T, Rosskamp R, Russell K, Zhou J, Amrite A, Hoppe B; PHYOX2 study investigators. Baum MA, et al. Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22. Kidney Int. 2023. PMID: 36007597 Free article. Clinical Trial.
Primary Hyperoxaluria.
Jiang D, Geng H. Jiang D, et al. N Engl J Med. 2017 Apr 13;376(15):e33. doi: 10.1056/NEJMicm1609986. N Engl J Med. 2017. PMID: 28402768 Free article. No abstract available.
Oxalate Maculopathy.
Kourti P, Gonzalez-Martin J, Yeo DCM. Kourti P, et al. Ophthalmol Retina. 2020 Sep;4(9):898. doi: 10.1016/j.oret.2020.04.008. Ophthalmol Retina. 2020. PMID: 32896362 No abstract available.
Hyperoxaluria: a gut-kidney axis?
Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Robijn S, et al. Kidney Int. 2011 Dec;80(11):1146-58. doi: 10.1038/ki.2011.287. Epub 2011 Aug 24. Kidney Int. 2011. PMID: 21866092 Free article. Review.
1,186 results